|
|
"Alpha Particle-emitting Erb-2 Tumor-targeting Peptides" - Topic 255
|
N43CO900062-000
|
$150,000
|
$37,500
|
Testa, Richard
|
ALPHAMED INC:1120333
|
|
|
4D IMRT: Stereotactic body radiotherapy for lung cancer
|
2R01CA093626-06A2
|
$318,449
|
$318,449
|
KEALL, PAUL
|
STANFORD UNIVERSITY
|
|
|
A Computational Platform for Analyzing and Visualizing Integrated TCGA Data in th
|
5R21CA135870-02
|
$142,200
|
$46,926
|
SANDER, CHRIS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
A Genetic Test for Lung Cancer Early Detection
|
5R03CA133956-02
|
$75,000
|
$75,000
|
Jiang, Feng
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
A Hospital-based Case-Control Study of Non-smoking Women in Xuan Wei and Fu Yuan,
|
ZIA CP010121-10349
|
$368,830
|
$368,830
|
Lan
|
DCEG (NCI)
|
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
5R01CA122128-02
|
$593,253
|
$563,590
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
A lung cancer symptom assessment and management intervention
|
5R01CA125256-02
|
$484,725
|
$484,725
|
COOLEY, MARY
|
DANA-FARBER CANCER INSTITUTE
|
|
|
A Molecular Basis for Neuroendocrine Carcinogenesis
|
5R01CA112405-05
|
$233,253
|
$233,253
|
GRIMES, H
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
A mouse model of stem cell deregulation and lung cancer
|
5R01CA076354-09
|
$264,921
|
$264,921
|
LOCKER, JOSEPH
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
|
A Multilevel Analysis of Predictors of Successful Teen Smoking Cessation in the N
|
5R03CA136013-02
|
$73,250
|
$73,250
|
Branstetter, Steven
|
WEST VIRGINIA UNIVERSITY
|
|
|
A multiplex genome-wide shRNA screening platform for cancer-lethal gene discovery
|
1R33CA140039-01
|
$361,095
|
$361,095
|
ELLEDGE, STEPHEN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
A Novel Bayesian Model Averaging Approach for Genome Wide Association Studies
|
1R03CA141998-01
|
$77,000
|
$77,000
|
SWARTZ, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$340,155
|
$340,155
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
A Phase I/II Clinical Trial of Intravenous (I.V.) Calcitriol with Fixed Doses of
|
5R21CA128193-03
|
$378,381
|
$378,381
|
RAMNATH, NITHYA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
A randomized phase II study of erlotinib with or without the anti-IGF-1R monoclon
|
5R21CA135595-02
|
$348,354
|
$348,354
|
Camidge, Ross
|
UNIVERSITY OF COLORADO DENVER
|
|
|
A Sensitive and Automated Diagnostic Assay for Lung Cancer
|
5R21CA135382-02
|
$168,750
|
$168,750
|
Jiang, Feng
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
A Simulation of Tobacco Policy, Smoking and Lung Cancer
|
5U01CA097450-08
|
$219,177
|
$219,177
|
LEVY, DAVID
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$13,306
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$11,610
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$850,624
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Accurate Models for Predicting Radiation-Induced Injury
|
5R01CA115748-04
|
$226,927
|
$113,464
|
DAS, SHIVA
|
DUKE UNIVERSITY
|
|
|
ACOSOG Central Specimen Bank
|
5U24CA114736-05
|
$408,191
|
$81,638
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
|
ACOSOG Non Competing Renewal
|
5U10CA076001-13
|
$3,062,358
|
$888,084
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
|
Activation of checkpoint pathways in cancer
|
5R01CA118827-04
|
$186,141
|
$186,141
|
Halazonetis, Thanos
|
UNIVERSITY OF GENEVA
|
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$1,345,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
|
Addressing Parental Smoking by Changing Pediatric Office Systems
|
5R01CA127127-03
|
$612,441
|
$581,819
|
WINICKOFF, JONATHAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Adenovirus-host interactions and in vivo virus targeting
|
1R01CA141439-01A2
|
$548,316
|
$548,316
|
SHAYAKHMETOV, DMITRY
|
UNIVERSITY OF WASHINGTON
|
|
|
Advanced Anatomic and Functional Response Assessment in Lung Cancer
|
5R01CA125143-03
|
$355,300
|
$355,300
|
Schwartz, Lawrence
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer
|
5R01CA124640-03
|
$308,750
|
$308,750
|
SPIRA, Avrum
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Aldo-Keto Reductases and PAH Metabolism/Activation
|
2R01CA039504-23
|
$289,179
|
$289,179
|
Penning, Trevor
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Alpha-1 AD Carriers and Lung Cancer Risk
|
5R01CA080127-09
|
$451,218
|
$451,218
|
YANG, PING
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$1,112,049
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
An Econometric Analysis of Cigarette Price Search and Tax Incidence
|
5R21CA131600-02
|
$138,600
|
$131,670
|
KENKEL, DONALD
|
CORNELL UNIVERSITY ITHACA
|
|
|
An Innovative Telephone Intervention for HIV+ Smokers
|
5R01CA097893-04
|
$478,413
|
$454,492
|
GRITZ, ELLEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-03
|
$429,479
|
$42,948
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
|
An Integrative Genomics Data Viewer to Support the TCGA Project
|
5R21CA135827-03
|
$205,500
|
$67,815
|
MESIROV, JILL
|
BROAD INSTITUTE, INC.
|
|
|
Analyses of human T regulatory cells
|
ZIA BC 010973
|
$283,284
|
$28,328
|
Tsang, Kwong
|
CCR (NCI)
|
|
|
Analyses of the Molecular Functions for D-Cyclins
|
2R01CA108420-06A1
|
$449,514
|
$148,340
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
|
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
|
ZIA BC 010425
|
$396,900
|
$39,690
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-07
|
$344,459
|
$172,230
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Analysis of Tobacco Industry Documents
|
2R01CA087472-10
|
$665,815
|
$565,943
|
GLANTZ, STANTON
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Angiogenesis imaging
|
ZIA BC 010714
|
$580,384
|
$58,038
|
Choyke, Peter
|
CCR (NCI)
|
|
|
Angioprevention of Lung Tumorigenesis by Silibinin
|
5R01CA113876-05
|
$288,389
|
$273,970
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Anti-Smoking Video Game for Pre-adolescent Girls
|
2R44CA112875-02A2
|
$830,241
|
$788,729
|
Root, Dana
|
GABRIEL INTERACTIVE, INC.
|
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
5P01CA043904-18
|
$3,001,468
|
$750,367
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Antibody Therapy of Cancer
|
ZIA BC 010891
|
$487,301
|
$194,920
|
Ho, Mitchell
|
CCR (NCI)
|
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,020,404
|
$202,040
|
Berzofsky, Jay
|
CCR (NCI)
|
|
|
Appalachia Community Cancer Network
|
3U01CA114622-05S1
|
$45,356
|
$14,967
|
Dignan, Mark
|
UNIVERSITY OF KENTUCKY
|
|
|
Appalachia Community Cancer Network
|
3U01CA114622-05S2
|
$86,763
|
$28,632
|
Dignan, Mark
|
UNIVERSITY OF KENTUCKY
|
|
|
Appalachia Community Cancer Network
|
5U01CA114622-05
|
$1,088,646
|
$359,253
|
Dignan, Mark
|
UNIVERSITY OF KENTUCKY
|
|
Total relevant funding to Lung for this search: $246,936,061
|
